Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody

Catalog No. ABIN7597963

The Humanized Chimeric anti-FCGRT (Rozanolixizumab Biosimilar) antibody has been validated for . It is suitable to detect FCGRT (Rozanolixizumab Biosimilar) in samples from Human.

Quick Overview for Recombinant FCGRT (Rozanolixizumab Biosimilar) antibody (ABIN7597963)

Target: FCGRT (Rozanolixizumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Humanized

Clonality: Chimeric

Conjugate: This FCGRT (Rozanolixizumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-FCGRT (Rozanolixizumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Rozanolixizumab Biosimilar Antibody

Specificity: IgG Fc fragment receptor transporter alpha chain, IgG receptor FcRn large subunit p51, FcRn, FCGRT, FCRN, Neonatal Fc receptor

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG4 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 1 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for FCGRT (Rozanolixizumab Biosimilar)

Target: FCGRT (Rozanolixizumab Biosimilar)

Alternative Name: Rozanolixizumab Biosimilar

Target Type: Biosimilar

Background: IgG Fc fragment receptor transporter alpha chain, IgG receptor FcRn large subunit p51, FcRn, FCGRT, FCRN, Neonatal Fc receptor

UniProt: P55899

CAS-No: 1584645-37-3